Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0036690 (
sepsis
)
59,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Septicaemia
caused by
Yersinia
pseudotuberculosis in a female patient, aged 22, is reported. She had suffered from a chronic active hepatitis for 14 years and had been treated with corticosteroids and azathioprine. The Y. pseudotuberculosis septicaemia responded well to treatment with doxycycline orally, but the patient died 2 weeks later because of excessive bleeding from varicose veins of the oesophagus.
...
PMID:Yersinia pseudotuberculosis as the cause of septicaemia in a patient with liver cirrhosis. A case report. 702 Mar 42
Enteral
yersiniosis
is caused either by Y. enterocolitica 0-group I (syn. serotype 0:3) and 0-group V (syn. serotype 0:9) or Y. pseudotuberculosis type I-VI. The clinical symptoms are mostly like enteritis, enterocolitis, acute abdomen, mesenteric lymphadenitis, or ileitis terminalis. Post-infection reactions are possible like
septicemia
, arthritis and erythema nodosum. Only cultural and serological examinations confirm the diagnosis of enteral
yersiniosis
. In the judgement of serological results it is necessary to consider the cross-reactions of Y. enterocolitica 0-group V to Brucella abortus, Brucella melitensis and Brucella suis and also to the antigenic community of Y. pseudotuberculosis type II respectively IV to Salmonella group B respectively D. With exception of
septicemia
, it is not necessary to treat enteral
yersiniosis
with antibiotics.
...
PMID:[Enteral yersiniosis--a serious disease? Current knowledge of clinical aspects, diagnosis and therapy]. 709 94
Four recent cases of
Yersinia
enterocolitica infections from Florida are discussed. Two of the cases presented as acute mesenteric lymphadenitis, and the other two presented as
septicemia
. Three of the isolates were an uncommon serotype, O:2,3, and the fourth was serotype O:5. The increasing occurrence of Y. enterocolitica in semitropical areas of the United States is emphasized.
...
PMID:Infections due to Yersinia enterocolitica serotypes O:2,3 and O:4 acquired in South Florida. 724 Apr 1
A 66-year-old man had pneumonia, lung abscesses, and mediastinal adenopathy develop due to
Yersinia
enterocolitica. There was no evidence of
septicemia
or acute gastrointestinal disease. Diagnosis was confirmed by cultures of a transtracheal aspirate and sputum. Treatment with cefamandole nafate, which had not been used previously in Y enterocolitica lung disease, resulted in cure.
...
PMID:Yersinia enterocolitica lung infection. 728 67
We present a patient with
Yersinia
enterocolitica
septicemia
who relapsed after a course of apparently appropriate antibiotic therapy. A literature review of successfully managed patients with this infection suggests clinical efficacy of aminoglycosides if therapy is continued for at least two weekon are presented. Close follow-up after therapy is required for early recognition and prompt treatment of relapse.
...
PMID:Yersinia enterocolitica septicemia. 735 9
Human
Yersinia
enterocolitica
septicemia
is an uncommon condition. Four new cases are reported here and a review is made of 51 others taken from medical literature.
Septicemia
caused by this microorganism occurs more frequently in the young and in the elderly, and usually involves patients havig previous liver or blood disorders, diabetes mellitus, and other debilitating diseases. Clinically it is indistinguishable from
sepsis
caused by other organisms of Enterobacteriaceae, but it is important that the clinician bear its existence in mind, since
Yersinia
enterocolitica strains are usually resistant to beta-lactam antibiotics, whereas they are susceptible to the aminoglycosides and co-trimoxazole, among others. Susceptibilities in the blood isolates from our patients, and in another ten fecal isolates from eight other patients showed the previously described pattern. Our isolates, however, were all susceptible to the new cephalosporins, cefamandole and cefoxitin, and to the experimental ones, HR-756, T-1551, and Ly-127.935.
...
PMID:Yersinia enterocolitica Septicemia. 742 22
Infections due to
Yersinia
enterocolitica are usually limited to the bowel. When infection is generalized, the role of iron overload and iron chelation has been discussed. We report the case of a 55 year-old patient with sideroblastic anemia who received repetitive transfusions and deferoxamine for 4 years and heme arginate for 2 months, and who was admitted in our institution for
Yersinia
enterocolitica
sepsis
. Treatment by third-generation cephalosporins and aminoglycosides has allowed favorable outcome.
...
PMID:[Yersinia enterocolitica septicemia, iron overload and deferoxamine]. 748 Nov 60
A 26 yr old woman was transfused after her baby was delivered by Caesarian section. During transfusion of the second pack of concentrated erythrocytes, she became acutely febrile. She then became shocked and gravely ill.
Yersinia
enterocolitica serogroup O:3 was recovered by blood culture from the patient and from the remnant of the bag of blood (but not the segments). The blood donor had suffered no illnesses. The patient received intensive treatment including antibiotics and made a slow recovery.
Yersinia
enterocolitica contaminated blood is a rare cause of potentially fatal post transfusion
septicemia
. Prompt recognition of the endotoxemia with cessation of the transfusion of the contaminated blood, although desirable does not seem to alter the outcome. There is no known effective measure to prevent such reactions.
...
PMID:Transfusion reaction due to Yersinia enterocolitica and review of other reported cases. 756 39
Endocarditis is a rare manifestation of Yersinia enterocolitica infection. The case of a 45-year-old man who presented with high fever and in whom prosthetic valve
Yersinia
enterocolitica endocarditis was diagnosed is described. The patient was successfully treated with ceftriaxone plus tobramycin, as proved by negative cultures of the prosthesis removed at the end of therapy. Including the patient reported, only 12 cases of
Yersinia
enterocolitica endocarditis have been published to date, two of which describe prosthetic cardiac valve endocarditis. The clinical characteristics do not distinguish
septicemia
from involvement limited to the cardiac valves. Diagnosis, however, has been improved by progress in echocardiography. Prognosis is grave but can be ameliorated if appropriate antimicrobial agents are administered, i.e. the combination of a third-generation cephalosporin plus an aminoglycoside. Fluroquinolones may also constitute an attractive therapeutic alternative.
...
PMID:Yersinia enterocolitica endocarditis: case report and literature review. 775 78
Yersinia
enterocolitica has been described with increasing frequency in the United States. Commonly, Y enterocolitica is a self-limiting gastrointestinal disorder, but occasionally it can lead to fulminant infection. This case report describes a 3-week-old male who succumbed to Y enterocolitica
sepsis
and reviews the literature.
...
PMID:Yersinia enterocolitica sepsis in a 3-week-old child. 780 64
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>